Paucity of laboratory-confirmed failures of high-dose influenza vaccine in an elderly population, 2012-2013. .

References 1. Bittner MJ, Gorby GL, Parks CC. Absence of laboratoryconfirmed failures of high-dose influenza vaccine in an elderly population. WMJ. 2013;112(2):45. 2. Temte JL. Commentary: Solid evidence is lacking, but signs are hopeful. WMJ. 2013;112(2):45. 3. DiazGranados CA, Dunning AJ, Kimmel M, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med. 2014; 371(7):635645. 4. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342(25):18871892. 5. Centers for Disease Control and Prevention. Estimated influenza illnesses and hospitalizations averted by influenza vaccination—United States, 2012–13 influenza season. MMWR Morb Mortal Wkly Rep. 2013;62(49):9971000. 6. Greenberg D. Fluzone high-dose vaccine efficacy trial results. Slide presentation at October 23-24, 2013 meeting of the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention. http://www.cdc.gov/vaccines/acip/meetings/ downloads/slides-oct-2013/04-Fluzone-Greenberg.pdf. Accessed September 12, 2014. Paucity of Laboratoryconfirmed Failures of High-dose Influenza Vaccine in an Elderly Population, 2012-2013